Alkermes (ALKS) Consolidated Net Income (2010 - 2026)
Alkermes (ALKS) posted quarterly Consolidated Net Income of $524000.0 for Q2 2026, up 100.79% quarter-over-quarter from -$66.5 million in Q1 2026.
Alkermes (ALKS) Consolidated Net Income (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Consolidated Net Income for 17 consecutive years, with $524000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Consolidated Net Income changed N/A year-over-year to $524000.0; the TTM figure through Jun 2026 stood at -$16.6 million (down 2699.53% YoY), while the FY2025 annual figure was $241.7 million, up 4273.82% from the prior year.
- Consolidated Net Income climbed to $524000.0 in Q2 2026 per ALKS's latest filing, from -$66.5 million in the prior quarter.
- Across five years, Consolidated Net Income topped out at $87.7 million in Q4 2022 and bottomed at -$66.5 million in Q1 2026.
- Historically, Consolidated Net Income has averaged -$15.3 million across 5 years, with a median of -$30.1 million in 2022.
- Annual changes were most pronounced in 2022 — Consolidated Net Income sank 1374.79% — and 2025, when it soared 4309.91%.
- Alkermes' Consolidated Net Income stood at $87.7 million in 2022, then sank by 146.58% to -$40.9 million in 2023, then jumped by 102.74% to $1.1 million in 2024, then jumped by 4309.91% to $49.4 million in 2025, then tumbled by 98.94% to $524000.0 in 2026.
- Business Quant data shows ALKS's Consolidated Net Income at $524000.0 in Q2 2026, -$66.5 million in Q1 2026, and $49.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.02 Bn | 7.37 Bn | 397.90 Mn | 524,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 524,000.00 |
| Mar 31, 2026 | -66.53 Mn |
| Dec 31, 2025 | 49.39 Mn |
| Dec 31, 2024 | 1.12 Mn |
| Sep 30, 2024 | -481,000.00 |
| Jun 30, 2024 | -3.91 Mn |
| Mar 31, 2024 | -2.52 Mn |
| Dec 31, 2023 | -40.86 Mn |
| Sep 30, 2023 | -45.35 Mn |
| Jun 30, 2023 | -42.08 Mn |
| Mar 31, 2023 | -36.52 Mn |
| Dec 31, 2022 | 87.72 Mn |
| Sep 30, 2022 | -63.97 Mn |
| Jun 30, 2022 | -30.14 Mn |
| Mar 31, 2022 | -35.90 Mn |
| Dec 31, 2021 | 125.44 Mn |
| Sep 30, 2021 | -28.99 Mn |
| Jun 30, 2021 | 2.36 Mn |
| Mar 31, 2021 | -22.42 Mn |
| Dec 31, 2020 | -42.64 Mn |